login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
VIKING THERAPEUTICS INC (VKTX) Stock News
USA
- NASDAQ:VKTX -
US92686J1060
-
Common Stock
34.42
USD
+0.5 (+1.47%)
Last: 10/24/2025, 8:01:07 PM
34.594
USD
+0.17 (+0.51%)
After Hours:
10/24/2025, 8:01:07 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
VKTX Latest News, Press Relases and Analysis
All
Press Releases
4 days ago - By: Chartmill
Viking Therapeutics (NASDAQ:VKTX) Reports Q3 2025 Earnings Miss and 2.8% After-Hours Decline
4 days ago - By: Zacks Investment Research
- Mentions:
ALNY
ALKS
HOWL
Viking Therapeutics Posts Wider-Than-Expected Loss in Q3, Sales Nil
4 days ago - By: The Motley Fool
Here's Why This Obesity Drug Company's Share Price Soared Today
4 days ago - By: Benzinga
Why Is Viking Therapeutics Stock Rising Today?
4 days ago - By: Stocktwits
- Mentions:
QUSA
ITOT
MS
Viking Therapeutics Stock Soars After Morgan Stanley’s Price Target Implies A Potential 225% Upside
4 days ago - By: Zacks Investment Research
- Mentions:
AZN
PFE
NVO
LLY
Lilly Up 10% in a Month: Should You Buy, Sell or Hold the Stock?
4 days ago - By: Zacks Investment Research
- Mentions:
NVO
LLY
How Will Ozempic and Wegovy Sales Aid NVO's Upcoming Q3 Results?
4 days ago - By: Investor's Business Daily
- Mentions:
LLY
Viking Bolts Higher On 'Lightning' Speed Enrollment In Obesity Studies
4 days ago - By: Viking Therapeutics, Inc.
Viking Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
6 days ago - By: Benzinga
Earnings Preview For Viking Therapeutics
6 days ago - By: Viking Therapeutics, Inc.
Viking Therapeutics Announces Initiation of VK2735 Maintenance Dosing Clinical Trial in Patients with Obesity
7 days ago - By: The Motley Fool
- Mentions:
LLY
NVO
MS
These 3 Obesity Drug Stocks Are Set to Soar This Fall and Beyond
9 days ago - By: Zacks Investment Research
Viking Therapeutics, Inc. (VKTX) Stock Dips While Market Gains: Key Facts
11 days ago - By: Viking Therapeutics, Inc.
Viking Therapeutics to Report Financial Results for Third Quarter 2025 on October 22, 2025
21 days ago - By: Stocktwits
- Mentions:
LLY
PFE
MTSR
Viking Therapeutics Ignites Retail-Trader Frenzy Amid Deal Speculation, Upcoming Trial Catalysts
24 days ago - By: Zacks Investment Research
Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know
a month ago - By: Zacks Investment Research
- Mentions:
NVO
LLY
Can NVO Maintain Obesity Leadership With Next-Generation Candidates?
a month ago - By: Stocktwits
- Mentions:
PFE
MTSR
ETNB
Viking Therapeutics Stock Gets Boost From Pfizer-Metsera Deal, Says BTIG — Retail Slams Rivals For Buying ‘Inferior Pipelines’
a month ago - By: Zacks Investment Research
- Mentions:
NVO
LLY
AMGN
NVO Stock Rises on Upbeat Phase III Data for Cagrilintide in Obesity
a month ago - By: Zacks Investment Research
Viking Therapeutics, Inc. (VKTX) Stock Falls Amid Market Uptick: What Investors Need to Know
Please enable JavaScript to continue using this application.